Hinge Health, Inc.

NYSE:HNGE

Medical - Healthcare Information Services

Healthcare
$114.53 -0.36%

-$0.24 today

Market cap
$9.31B
Beta
1.99
P/E (TTM)
-10.3
EPS (TTM)
-$6.49
52W Low $30.08High $70.72

Volume 1.23M

Average 1.34M

HNGE Stock-Based Compensation

Employee pay granted in shares or options; a non-cash expense that dilutes existing shareholders.

Hinge Health, Inc.NYSE: HNGE

Stock-Based Compensation · Q2 FY2026 · quarter ended Jun 2026

Stock-based compensation declines year over year

Q2 FY2026 stock-based compensation of $19.09M fell 96.8% year over year, behind the -86.0% change in trailing-twelve-month stock-based compensation. Sequentially, it rose 63.3% from the prior quarter.

Context

  • Stock-based compensation amounted to 109.4% of revenue in FY2025, up 109.2 pp from a year earlier.
  • Stock-based compensation increased in 1 of the last 2 fiscal years.
  • FY2025 was the highest annual figure in the 3 fiscal years shown.

What to watch

Whether quarterly growth recovers from -96.8% toward the trailing-twelve-month pace of -86.0%.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterJun 2026
$19.09M+63.3% QoQ
Last fiscal yearDec 2025
$643.01M+86910.7% YoY
LTMJun 2026
$82.8M-86.0% YoY
Stock-Based Compensation past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-96.8%——
1 year+86910.7%——
3-year CAGR———
5-year CAGR——
10-year CAGR——

Stock-Based Compensation history

USD · from the cash flow

Latest · FY2025
643.01M USD
Year-over-year change
+86910.7%
2-year CAGR
+1877.1%

Stock-Based Compensation vs competitors

How HNGE compares with its peers on the latest reported figures

  • HNGE's LTM Jun 2026 stock-based compensation of $82.8M is the largest of the 5 companies compared; the peer median is $20.29M.
  • Its year-over-year change of -86.0% is the lowest of 5, against a peer median of +11.0%.
  • Stock-based compensation amounts to 11.5% of revenue for HNGE, versus a peer median of 1.0%.
HNGE Competitors Peer median
Stock-Based Compensation for HNGE and competitors
Company Period LTM YoY 3-year CAGR% of revenue
HNGEHinge Health, Inc.LTM Jun 2026$82.8M -86.0%—11.5%
SNNSmith & Nephew plcFY2025$43M +7.5%+2.4%0.7%
ENOVEnovis CorporationLTM Apr 2026$26.26M -14.3%-5.5%1.2%
OMDAOmada HealthLTM Mar 2026$14.32M +52.4%+24.9%5.1%
USPHU.S. Physical Therapy, Inc.LTM Mar 2026$6.5M +14.5%+4.4%0.9%
Peer median (excluding HNGE) $20.29M+11.0%+3.4%1.0%

Competitors are the stored peer set for HNGE. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income(108.14M)(11.93M)(528.26M)
Depreciation & Amortization5.63M5.95M5.13M
Deferred Income Tax(473K)(585K)53K
Stock-Based Compensation1.65M739K643.01M
Change in Working Capital9.41M13.5M(2.01M)
Accounts Receivables(23.13M)(1.34M)(26.63M)
Inventory10.57M608K(4.76M)
Accounts Payables0(10.98M)29.41M
Other Working Capital21.97M25.21M(31K)
Other Non-Cash Items28.02M41.33M53.52M
Operating Cash Flow(63.91M)49M171.44M
Capital Expenditures(4.62M)(3.77M)(708K)
Acquisitions (Net)00(4M)
Purchases of Investments(453.34M)(324.54M)(472.29M)
Sales of Investments459.45M346.63M368.59M
Other Investing Activities(2.64M)(2.73M)(5.36M)
Investing Cash Flow1.5M18.31M(113.76M)
Debt Repayment000
Common Stock Issued0610K265.2M
Common Stock Repurchased00(65.03M)
Dividends Paid000
Other Financing Activities(3M)(2.81M)(350.64M)
Financing Cash Flow(3M)(2.2M)(150.47M)
Effect of Forex Changes000
Net Change in Cash(65.41M)65.11M(92.79M)
Free Cash Flow(68.52M)45.23M170.73M

Hinge Health, Inc.

NYSE:HNGE

Intrinsic Alpha fair value

Locked

Current Price

$114.53

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.